Provided by Tiger Fintech (Singapore) Pte. Ltd.

bioAffinity Technologies, Inc.

0.2702
-0.0220-7.53%
Volume:2.36M
Turnover:618.86K
Market Cap:4.21M
PE:-0.34
High:0.2810
Open:0.2810
Low:0.2505
Close:0.2922
Loading ...

Physicians’ Case Studies Offer Insight into Use and Benefit of CyPath® Lung in Avoiding Unnecessary Invasive Procedures and Detecting Lung Cancer

Business Wire
·
13 Mar

BioAffinity accelerates CyPath Lung amid $4M in annual cost savings at PPLS

TIPRANKS
·
06 Mar

bioAffinity Technologies Announces Targeted Actions to Cut $4 Million in Costs and Drive Cypath® Lung Sales Growth

THOMSON REUTERS
·
06 Mar

bioAffinity Technologies Inc - Announces 38% Workforce Reduction at Ppls

THOMSON REUTERS
·
06 Mar

bioAffinity Technologies Announces Targeted Actions to Cut $4 Million in Costs and Drive CyPath® Lung Sales Growth

Business Wire
·
06 Mar

bioAffinity Technologies Raises $1.4 Million After Warrant Exercise

MT Newswires Live
·
27 Feb

WallachBeth Capital Announces Closing of bioAffinity Technologies Warrant Inducement Transaction for Aggregate Gross Proceeds of $1.4 Million

PR Newswire
·
27 Feb

Press Release: WallachBeth Capital Announces bioAffinity Technologies Warrant Inducement for Aggregate Gross Proceeds of $1.4 Million

Dow Jones
·
26 Feb

bioAffinity Technologies Announces Warrant Inducement for Aggregate Gross Proceeds of $1.4 Million

Business Wire
·
25 Feb

Zacks Initiates Coverage of bioAffinity With Neutral Recommendation

Zacks
·
06 Feb

The Zacks Analyst Blog Highlights Amazon, Bank of America, Caterpillar, NVE and bioAffinity

Zacks
·
06 Feb

Top Research Reports for Amazon.com, Bank of America & Caterpillar

Zacks
·
06 Feb

BioAffinity Technologies Says Australian Patent Office Accepts Lung Cancer Test Application

MT Newswires Live
·
23 Jan

BRIEF-Bioaffinity Technologies Announces Acceptance Of Patent Application For Early-Stage Lung Cancer Diagnostic

Reuters
·
22 Jan

bioAffinity Technologies Inc - Australian Patent for Cypath Lung Test to Expire in 2042

THOMSON REUTERS
·
22 Jan

bioAffinity Technologies Announces Acceptance of Patent Application for Early-Stage Lung Cancer Diagnostic

THOMSON REUTERS
·
22 Jan